FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204123852> ?p ?o ?g. }

• W3204123852 abstract "Background: Fragile X syndrome (FXS) is a monogenic disorder characterized by high rates of autism spectrum disorder (ASD) and anxiety. A longstanding “hyperarousal hypothesis” in FXS has argued that ANS dysfunction underpins many symptoms of FXS. However, the developmental onset and trajectory of ANS dysfunction, as well as the consequences of ANS dysfunction on later psychiatric symptoms, remain poorly understood in FXS. Insight into the emergence, trajectory, and consequences of ANS dysfunction across early development in FXS has critical implications for prevention, intervention, and optimal outcomes in both typical and atypical development. This longitudinal study investigated whether and when males with FXS evidence atypical ANS function from infancy through early childhood, and how trajectories of ANS function across infancy and early childhood predict ASD and anxiety symptom severity later in development. Methods: Participants included 73 males with FXS and 79 age-matched typically developing (TD) males. Baseline heart activity was recorded at multiple assessments between 3 and 83 months of age, resulting in 372 observations. General arousal and parasympathetic activity were indexed via interbeat interval (IBI) and respiratory sinus arrhythmia (RSA), respectively. ASD and anxiety symptoms were assessed at 36 months of age or later in a subgroup of participants (FXS n = 28; TD n = 25). Results: Males with FXS exhibited atypical patterns of developmental change in ANS function across infancy and early childhood. As a result, ANS dysfunction became progressively more discrepant across time, with the FXS group exhibiting significantly shorter IBI and lower RSA by 29 and 24 months of age, respectively. Shorter IBI at 24 months and a flatter IBI slope across development predicted elevated anxiety symptoms, but not ASD symptoms, later in childhood in both FXS and TD males. Reduced RSA at 24 months predicted elevated ASD symptoms, but not anxiety symptoms, in both groups. Developmental change in RSA across early development did not predict later anxiety or ASD symptoms. Conclusion: This is the first longitudinal study to examine the “hyperarousal hypothesis” in infants and young children with FXS. Findings suggest that hyperarousal (i.e., shorter IBI, lower RSA) is evident in males with FXS by 24–29 months of age. Interestingly, unique aspects of early ANS function differentially relate to later ASD and anxiety symptoms. General arousal, indexed by shorter IBI that becomes progressively more discrepant from TD controls, predicts later anxiety symptoms. In contrast, parasympathetic-related factors, indexed by lower levels of RSA, predict ASD symptoms. These findings support the “hyperarousal hypothesis” in FXS, in that ANS dysfunction evident early in development predicts later-emerging symptoms of ASD and anxiety. This study also have important implications for the development of targeted treatments and interventions that could potentially mitigate the long-term effects of hyperarousal in FXS." @default.
• W3204123852 created "2021-10-11" @default.
• W3204123852 creator A5019354591 @default.
• W3204123852 creator A5035423814 @default.
• W3204123852 creator A5036250575 @default.
• W3204123852 creator A5040984852 @default.
• W3204123852 creator A5055780470 @default.
• W3204123852 creator A5073090580 @default.
• W3204123852 creator A5081059739 @default.
• W3204123852 date "2021-10-06" @default.
• W3204123852 modified "2023-10-17" @default.
• W3204123852 title "Trajectories of Heart Activity Across Infancy to Early Childhood Differentially Predict Autism and Anxiety Symptoms in Fragile X Syndrome" @default.
• W3204123852 cites W1533900467 @default.
• W3204123852 cites W1536629073 @default.
• W3204123852 cites W1871561947 @default.
• W3204123852 cites W1894178656 @default.
• W3204123852 cites W1965208129 @default.
• W3204123852 cites W1966316282 @default.
• W3204123852 cites W1980552416 @default.
• W3204123852 cites W1982619374 @default.
• W3204123852 cites W1994817684 @default.
• W3204123852 cites W2001828097 @default.
• W3204123852 cites W2003276089 @default.
• W3204123852 cites W2004056298 @default.
• W3204123852 cites W2008275147 @default.
• W3204123852 cites W2008969489 @default.
• W3204123852 cites W2015743906 @default.
• W3204123852 cites W2027485994 @default.
• W3204123852 cites W2028900007 @default.
• W3204123852 cites W2031303879 @default.
• W3204123852 cites W2032565367 @default.
• W3204123852 cites W2038561863 @default.
• W3204123852 cites W2047575683 @default.
• W3204123852 cites W2048798290 @default.
• W3204123852 cites W2060911896 @default.
• W3204123852 cites W2061565859 @default.
• W3204123852 cites W2066015718 @default.
• W3204123852 cites W2072765140 @default.
• W3204123852 cites W2075715910 @default.
• W3204123852 cites W2080929263 @default.
• W3204123852 cites W2085270294 @default.
• W3204123852 cites W2087859107 @default.
• W3204123852 cites W2095596613 @default.
• W3204123852 cites W2097431774 @default.
• W3204123852 cites W2102426591 @default.
• W3204123852 cites W2105279682 @default.
• W3204123852 cites W2108310602 @default.
• W3204123852 cites W2109269836 @default.
• W3204123852 cites W2114857415 @default.
• W3204123852 cites W2118182252 @default.
• W3204123852 cites W2119614961 @default.
• W3204123852 cites W2120574495 @default.
• W3204123852 cites W2122313235 @default.
• W3204123852 cites W2136167316 @default.
• W3204123852 cites W2136819764 @default.
• W3204123852 cites W2142483243 @default.
• W3204123852 cites W2144120285 @default.
• W3204123852 cites W2148916146 @default.
• W3204123852 cites W2149612743 @default.
• W3204123852 cites W2152601310 @default.
• W3204123852 cites W2154549730 @default.
• W3204123852 cites W2158596166 @default.
• W3204123852 cites W2163659027 @default.
• W3204123852 cites W2163674463 @default.
• W3204123852 cites W2409505391 @default.
• W3204123852 cites W2576957097 @default.
• W3204123852 cites W2594145120 @default.
• W3204123852 cites W2604161564 @default.
• W3204123852 cites W2622568430 @default.
• W3204123852 cites W2736454514 @default.
• W3204123852 cites W2782515409 @default.
• W3204123852 cites W2808872446 @default.
• W3204123852 cites W2898471971 @default.
• W3204123852 cites W2908599956 @default.
• W3204123852 cites W2908904948 @default.
• W3204123852 cites W2916113381 @default.
• W3204123852 cites W2921340391 @default.
• W3204123852 cites W292964 @default.
• W3204123852 cites W2944208537 @default.
• W3204123852 cites W2978018127 @default.
• W3204123852 cites W3049660335 @default.
• W3204123852 cites W3104878055 @default.
• W3204123852 cites W3125131852 @default.
• W3204123852 cites W3127305845 @default.
• W3204123852 cites W3128742666 @default.
• W3204123852 cites W3134065688 @default.
• W3204123852 cites W3137764769 @default.
• W3204123852 cites W4235772248 @default.
• W3204123852 doi "https://doi.org/10.3389/fpsyt.2021.727559" @default.
• W3204123852 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8526850" @default.
• W3204123852 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34690833" @default.
• W3204123852 hasPublicationYear "2021" @default.
• W3204123852 type Work @default.
• W3204123852 sameAs 3204123852 @default.
• W3204123852 citedByCount "5" @default.
• W3204123852 countsByYear W32041238522022 @default.
• W3204123852 countsByYear W32041238522023 @default.
• W3204123852 crossrefType "journal-article" @default.
• W3204123852 hasAuthorship W3204123852A5019354591 @default.
• W3204123852 hasAuthorship W3204123852A5035423814 @default.

• next